ABVC BioPharma, Inc. Increase (Decrease) in Income Taxes Payable
ABVC BioPharma, Inc. (ABVC) reported Increase (Decrease) in Income Taxes Payable of -$11.89 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2026-08-12
- ABVC BioPharma, Inc. increase (decrease) in income taxes payable for the quarter ending 2026-06-30 was -$5.95K.
- ABVC BioPharma, Inc. increase (decrease) in income taxes payable for the quarter ending 2026-03-31 was -$5.94K.
- ABVC BioPharma, Inc. increase (decrease) in income taxes payable for the quarter ending 2025-12-31 was $5.79K.
- ABVC BioPharma, Inc. increase (decrease) in income taxes payable for the quarter ending 2025-09-30 was -$17.35K.
- ABVC BioPharma, Inc. increase (decrease) in income taxes payable for fiscal 2025 was $11.96K.
- ABVC BioPharma, Inc. increase (decrease) in income taxes payable for fiscal 2024 was -$112.95K, a 200.00% decline from fiscal 2023.
- ABVC BioPharma, Inc. increase (decrease) in income taxes payable for fiscal 2023 was $112.95K.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$11.89K 10-Q · filed 2026-08-12 | -$6.09K derived: sum of 3 quarters · filed 2026-08-12 | -$23.45K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$5.94K 10-Q · filed 2026-05-18 | -$150.00 derived: sum of 2 quarters · filed 2026-05-18 | -$17.50K derived: sum of 3 quarters · filed 2026-05-18 | |
| 2025-12-31 | $5.79K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | -$11.56K derived: sum of 2 quarters · filed 2026-03-03 | $11.96K 10-K · filed 2026-03-03 | |
| 2025-09-30 | -$17.35K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | $6.17K 10-Q/A · filed 2026-03-03 | ||
| 2025-06-30 | $23.52K 10-Q · filed 2026-08-12 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-03-03 | -$112.95K 10-K · filed 2026-03-03 | |
| 2024-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | -$112.95K 10-Q/A · filed 2026-03-03 | ||
| 2024-06-30 | -$112.95K 10-Q · filed 2025-08-13 | |||
| 2023-12-31 | $112.95K 10-K · filed 2025-04-15 |